Helmut Butzkueven

Cited by

	All	Since 2016
Citations	15743	9408
h-index	58	45
i10-index	167	150

2200

1100

550

1650

20042005200620072008200920102011201220132014201520162017201820192020202173 100 141 181 236 288 468 486 735 988 1060 1335 1388 1403 1521 1698 2136 1172

Public access

View all

88 articles

14 articles

available

not available

Based on funding mandates

Co-authors

maria trojanoDipartimento di Scienze Mediche di Base, Neuroscienze ed Organi di Senso, Università degli StudiVerified email at uniba.it
Bruce V Taylormenzies Research Institute Tasmania University of TasmaniaVerified email at utas.edu.au
Anneke Van Der WaltAssociate Professor, Central Clinical School, Monash UniversityVerified email at monash.edu
Gary EganMonash Biomedical Imaging, Monash UniversityVerified email at monash.edu
Jim StankovichDepartment of Neuroscience, Monash University, AustraliaVerified email at monash.edu.au
Scott KolbeMonash UniversityVerified email at monash.edu
Ludwig KapposUniversity Hospital BaselVerified email at uhbs.ch
Justin Paul RubioAssociate Prof of Human Genetics, The Florey Institute of Neuroscience andVerified email at unimelb.edu.au
Ingrid van der MeiMenzies Institute for Medical Research, University of TasmaniaVerified email at utas.edu.au
Jeannette Lechner-ScottHunter Medical Research InstituteVerified email at health.nsw.gov.au
Vilija JokubaitisDepartment of Neuroscience, Monash UniversityVerified email at monash.edu
Maria Pia SormaniUniversity of GenoaVerified email at unige.it
Melanie BahloTheme Leader, Healthy Development and Ageing, The Walter and Eliza Hall Institute ofVerified email at wehi.edu.au
Gavin GiovannoniBarts and The London School of Medicine and DentistryVerified email at giovannoni.net
Michael BarnettThe University of Sydney / Brain and Mind CentreVerified email at sydney.edu.au
Ben EmeryOregon Health and Science UniversityVerified email at ohsu.edu
Shibeshih Mitiku BelachewBiogenVerified email at biogen.com
Andrew EvansReta Lila Weston Institute and the Royal Melbourne HospitalVerified email at pobox.com
Judith FieldResearch Scientist, CSL Ltd.Verified email at csl.com.au
Mark SleeFlinders University and Medical CentreVerified email at flinders.edu.au

Helmut Butzkueven

MSNI Research Group, Dept of Neuroscience, Central Clinical School, Monash University

Verified email at monash.edu

Multiple Sclerosis and Neuroimmunology


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis S Sawcer, G Hellenthal, M Pirinen, CCA Spencer, NA Patsopoulos, ... Nature 476 (7359), 214, 2011	2393	2011
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis AH Beecham, NA Patsopoulos, DK Xifara, MF Davis, A Kemppinen, ... Nature genetics 45 (11), 1353, 2013	961	2013
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity R Roxburgh, SR Seaman, T Masterman, AE Hensiek, SJ Sawcer, ... Neurology 64 (7), 1144-1151, 2005	858	2005
Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study IAF van der Mei, AL Ponsonby, T Dwyer, L Blizzard, R Simmons, ... Bmj 327 (7410), 316, 2003	664	2003
Gait and balance impairment in early multiple sclerosis in the absence of clinical disability CL Martin, BA Phillips, TJ Kilpatrick, H Butzkueven, N Tubridy, ... Multiple Sclerosis Journal 12 (5), 620-628, 2006	525	2006
Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20 Australia and New Zealand Multiple Sclerosis Genetics Consortium Nature genetics 41 (7), 824, 2009	457	2009
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study L Kappos, A Bar-Or, BAC Cree, RJ Fox, G Giovannoni, R Gold, ... The Lancet 391 (10127), 1263-1273, 2018	413	2018
Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia IAF van der Mei, AL Ponsonby, T Dwyer, L Blizzard, BV Taylor, T Kilpatrick, ... Journal of neurology 254 (5), 581-590, 2007	378	2007
Genome‐wide meta‐analysis identifies novel multiple sclerosis susceptibility loci NA Patsopoulos, ... Annals of neurology 70 (6), 897-912, 2011	309	2011
LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival H Butzkueven, JG Zhang, M Soilu-Hanninen, H Hochrein, F Chionh, ... Nature medicine 8 (6), 613-619, 2002	297	2002
Brain health: time matters in multiple sclerosis G Giovannoni, H Butzkueven, S Dhib-Jalbut, J Hobart, G Kobelt, G Pepper, ... Multiple sclerosis and related disorders 9, S5-S48, 2016	218	2016
Onset seizures independently predict poor outcome after subarachnoid hemorrhage H Butzkueven, AH Evans, A Pitman, C Leopold, DJ Jolley, AH Kaye, ... Neurology 55 (9), 1315-1320, 2000	216	2000
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis MS Stein, Y Liu, OM Gray, JE Baker, SC Kolbe, MR Ditchfield, GF Egan, ... Neurology 77 (17), 1611-1618, 2011	201	2011
Geographical variations in sex ratio trends over time in multiple sclerosis M Trojano, G Lucchese, G Graziano, BV Taylor, S Simpson Jr, V Lepore, ... PLOS one 7 (10), e48078, 2012	190	2012
Defining secondary progressive multiple sclerosis J Lorscheider, K Buzzard, V Jokubaitis, T Spelman, E Havrdova, ... Brain 139 (9), 2395-2405, 2016	171	2016
Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial D Cadavid, L Balcer, S Galetta, O Aktas, T Ziemssen, L Vanopdenbosch, ... The Lancet Neurology 16 (3), 189-199, 2017	169	2017
Association of initial disease-modifying therapy with later conversion to secondary progressive multiple sclerosis JWL Brown, A Coles, D Horakova, E Havrdova, G Izquierdo, A Prat, ... Jama 321 (2), 175-187, 2019	164	2019
Efficacy and safety of natalizumab in multiple sclerosis: interim observational programme results H Butzkueven, L Kappos, F Pellegrini, M Trojano, H Wiendl, RN Patel, ... Journal of Neurology, Neurosurgery & Psychiatry 85 (11), 1190-1197, 2014	146	2014
Replication of KIAA0350, IL2RA, RPL5 and CD58 as multiple sclerosis susceptibility genes in Australians JP Rubio, J Stankovich, J Field, N Tubridy, M Marriott, C Chapman, ... Genes & Immunity 9 (7), 624-630, 2008	145	2008
Switch to natalizumab versus fingolimod in active relapsing–remitting multiple sclerosis T Kalincik, D Horakova, T Spelman, V Jokubaitis, M Trojano, A Lugaresi, ... Annals of neurology 77 (3), 425-435, 2015	144	2015

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Upload PDF

Follow this author

Cited by

Co-authors